China Resources Pharmaceutical Group Investor Relations Material
Latest events
H2 2024
26 Mar, 2025
H1 2024
26 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from China Resources Pharmaceutical Group Limited
Access all reports
China Resources Pharmaceutical Group Limited is engaged in the manufacturing, distribution, and retail of pharmaceutical and healthcare products. The company’s business spans the production of Chinese and Western medicines, the distribution of medical devices and equipment, and the operation of retail pharmacy chains. The company is headquartered in Hong Kong, China, and its shares are listed on the SEHK.
Key slides for China Resources Pharmaceutical Group Limited
H1 2024
China Resources Pharmaceutical Group Limited
H2 2024
China Resources Pharmaceutical Group Limited
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
3320
Country
🇭🇰 Hong Kong